Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical breakthrough

Stanford Finds Brain Is Two Organs

Analysis based on 19 articles · First reported Sep 18, 2026 · Last updated Sep 24, 2026

Sentiment
5
Attention
2
Articles
19
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The discovery is a scientific milestone that could accelerate drug development for ALS and SMA, a long-term positive for biotechnology and pharmaceutical companies active in neurodegeneration research. Near-term market impact is limited because no commercial product or regulatory decision is involved, though it may modestly boost sentiment toward stem-cell and neuroscience-focused firms.

biotechnology pharmaceuticals healthcare

Researchers at Stanford University announced a major neuroscience discovery: the human brain is not a single organ but two separate nervous systems that evolved independently and later fused. The team, led by Kyle Loh with co-first authors Rayyan Jokhai and Carolyn Dundes, found that the forebrain and midbrain arise from progenitor cells expressing the gene Otx2, while the hindbrain arises from a distinct progenitor population expressing Gbx2, with fundamentally different DNA packaging locking each onto separate developmental paths. The work, published in Alto Neuroscience, overturns the long-held single-progenitor model of brain development. Using this insight, the researchers for the first time coaxed human pluripotent stem cells into functional hindbrain motor neurons in the laboratory. The same two-origin pattern was identified in chickens, zebrafish, and acorn worms, suggesting the split dates back at least 500 million years. The ability to grow hindbrain neurons is expected to accelerate research into neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), which destroy hindbrain motor neurons. The hindbrain also contains hunger-regulating circuits relevant to weight-loss drugs such as semaglutide. California Institute of Technology and University of California, San Francisco contributed to the study. Articles also referenced background material on ALS from the United Kingdom — National Health Service and ALS Association, and historical references to Lou Gehrig and Jean-Martin Charcot.

40 Alto Neuroscience published study
20 California Institute of Technology contributed to study
per
Kyle Loh, associate professor of developmental biology, is the senior author who led the discovery and its implications for growing hindbrain neurons.
Importance 90.0 Sentiment 10.0
per
Rayyan Jokhai is a co-first author who described the findings and the potential for modeling and treating SMA and ALS.
Importance 70.0 Sentiment 10.0
per
Carolyn Dundes is a co-first author who helped identify the separate developmental pathway of the hindbrain.
Importance 60.0 Sentiment 10.0
stock
Alto Neuroscience published the peer-reviewed study, reinforcing its standing as a leading venue for neuroscience research.
Importance 40.0 Sentiment 5.0
oth
California Institute of Technology contributed to the study, gaining minor reputational credit in the breakthrough.
Importance 20.0 Sentiment 5.0
stock
Novo Nordisk is indirectly relevant because the study notes hindbrain hunger circuits are the target of weight-loss drugs such as semaglutide, a potential long-term positive for its obesity franchise.
Importance 15.0 Sentiment 5.0
govactor
The United Kingdom — National Health Service was cited for background information on motor neurone disease; no direct role in the discovery.
Importance 10.0 Sentiment 0.0
ngo
The ALS Association was cited for background statistics on ALS; no direct role in the discovery.
Importance 10.0 Sentiment 0.0
per
Lou Gehrig was referenced historically as the baseball player whose name is associated with ALS; no role in the event.
Importance 5.0 Sentiment 0.0
per
Jean-Martin Charcot was referenced historically as the neurologist who first described motor neurone disease; no role in the event.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.